Navigation Links
Protein disables p53, drives breast cells toward cancer transition

HOUSTON - The recently identified TRIM24 protein plays an active role in pushing normal breast cells into rapid cell proliferation and, potentially, into breast cancer.

Reporting in the journal Nature, a team led by researchers at The University of Texas MD Anderson Cancer Center found that TRIM24 (tripartite motif-containing 24) pushes estrogen-responsive genes toward active expression. This expression, in turn, sets the stage for malignant transformation of breast cells. TRIM24 functions by reading a specific code, or signature, present at estrogen-regulated genes and recruiting estrogen receptors for gene activation. About 70 percent of breast cancers are estrogen receptor positive; their growth is driven by the hormone estrogen.

Tumor-suppressor labeled for destruction

TRIM24 is a chromatin regulator that normally maintains the tumor suppressor p53 at low levels until it is summoned to reduce cellular stress or DNA damage in cells. Abnormally high expression of TRIM24, however, suppresses p53 levels, making cells more vulnerable to the types of cellular damage that lead to cancer. In breast cells, high levels of TRIM24 also stimulate estrogen receptor activity, delivering a one-two punch that fuels cell proliferation and growth.

"We found that TRIM24 negatively regulates p53 by placing ubiquitin on it and thereby labeling it for destruction," said Michelle C. Barton, Ph.D., professor in the Department of Biochemistry and Molecular Biology at MD Anderson. "Two of TRIM24's structural domains indicated that it probably interacts with proteins called histones that spool DNA into chromatin. TRIM24 is an interpreter of specific modifications placed on histones that function like a barcode - we call this the histone code or histone barcode." TRIM24 then reads the particular barcode that the histone modifications spell out, receiving its instructions on such things as whether to activate a gene.

Barton added that these structural domains suggest that TRIM24 not only can read the histone code but is actually reading a very unusual alphabet spelling of the histone barcode. This unusual histone signature appears at estrogen-response elements-places in the DNA where estrogen receptors bind - and it is regulating estrogen-regulated genes that become overstimulated by TRIM24. These genes push cells into proliferation and probably into tumorigenesis.

Overexpressed TRIM24 cuts survival

When the researchers examined a number of breast cancer cell lines, they found that TRIM24 was overexpressed in each one. "Because TRIM24 is basically undetectable in normal cells," Barton said, "we believe that by virtue of its being overexpressed, it's negatively regulating p53 and overstimulating estrogen receptors that, in turn, promote the proliferation."

Collaboration with MD Anderson's Mien-Chie Hung, Ph.D., chair of the Department of Molecular and Cellular Oncology, further strengthened the case for TRIM24's role in breast cell proliferation and tumorigenesis. When pathologist Weiya Xia, M.D., screened biopsies of 128 breast cancer patients, she found that TRIM24 was overexpressed in 70 percent. These patients had a median overall survival rate of 50 months, meaning half of them survived at least to that point.

In 30 percent of the women, TRIM24 was either undetectable or expressed at very low levels. In these two groups, the women's breast cancer was non-metastatic, and 90 percent survived to 50 months.

Avenues of future research

"We propose that TRIM24 would be a great therapeutic target - the reason being that if you were to eliminate or inactivate TRIM24, you could potentially restart p53 function and decrease estrogen receptor function in breast tumor cells," Barton said. "In the case of ER-negative tumors, you might still have a chance to go for the p53, and in the case of breast cancers that are p53-negative you might still be able to go for the estrogen receptor."

"We're claiming that TRIM24 promotes tumor development," Barton continued, "and now we're trying to actually prove that by using mouse models in which we overexpress TRIM24 in mammary epithelium cells."


Contact: Scott Merville
University of Texas M. D. Anderson Cancer Center

Related medicine news :

1. Protein offers new clue to cause and treatment for kidney disease
2. Protein targeted to stop melanoma tumor growth
3. New Test Links Blood Protein to Heart Disease, Diabetes Risk
4. Scientists Find Protein That May Help Control Prostate Cancer
5. Neurological protein may hold the key to new treatments for depression
6. More Protein, Fewer Refined Carbs May Keep Weight Off
7. Protein found to predict brain injury in children on ECMO life support
8. Protein in the urine: A warning sign for cognitive decline
9. Scripps Research scientists identify first synthetic activator of 2 critical proteins
10. Scientists at IRB Barcelona and BSC publish the worlds largest video data bank of proteins
11. Protein Differences May Explain Long-Term HIV Control
Post Your Comments:
Related Image:
Protein disables p53, drives breast cells toward cancer transition
(Date:11/26/2015)... ... November 26, 2015 , ... ... mental health and wellness consultation, has collaborated with Women’s Web – an ... reader’s queries on topics on mental and emotional well-being relationship, life balance, ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology: